Grand Warszawski / Shutterstock.com
23 July 2019Big PharmaSaman Javed
UK High Court rules Roche patent is invalid
The English High Court has ruled that a patent owned by Roche should be revoked on grounds of insufficiency.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Big Pharma
1 May 2019 Amgen and Roche have filed a joint patent infringement claim against Samsung’s biopharmaceutical company Bioepis.
Big Pharma
31 October 2019 Roche has entered into a $200 million agreement to licence Dicerna’s GalXC RNAi platform technology to develop novel therapies for the treatment of chronic hepatitis B.
Generics
27 April 2021 The UK High Court has refused to invalidate an Alcon glaucoma treatment patent in a judgment handed down on Friday, April 23.
Editor's picks
Editor's picks
Big Pharma
1 May 2019 Amgen and Roche have filed a joint patent infringement claim against Samsung’s biopharmaceutical company Bioepis.
Big Pharma
31 October 2019 Roche has entered into a $200 million agreement to licence Dicerna’s GalXC RNAi platform technology to develop novel therapies for the treatment of chronic hepatitis B.
Generics
27 April 2021 The UK High Court has refused to invalidate an Alcon glaucoma treatment patent in a judgment handed down on Friday, April 23.
Big Pharma
1 May 2019 Amgen and Roche have filed a joint patent infringement claim against Samsung’s biopharmaceutical company Bioepis.
Big Pharma
31 October 2019 Roche has entered into a $200 million agreement to licence Dicerna’s GalXC RNAi platform technology to develop novel therapies for the treatment of chronic hepatitis B.
Generics
27 April 2021 The UK High Court has refused to invalidate an Alcon glaucoma treatment patent in a judgment handed down on Friday, April 23.